StocksFundsScreenerSectorsWatchlists
CVS

CVS - CVS Health Corp Stock Price, Fair Value and News

69.01USD+0.05 (+0.07%)Market Closed

Market Summary

CVS
USD69.01+0.05
Market Closed
0.07%

CVS Stock Price

View Fullscreen

CVS RSI Chart

CVS Valuation

Market Cap

86.8B

Price/Earnings (Trailing)

10.4

Price/Sales (Trailing)

0.24

EV/EBITDA

7.54

Price/Free Cashflow

8.35

CVS Price/Sales (Trailing)

CVS Profitability

Operating Margin

56.34%

EBT Margin

3.12%

Return on Equity

10.93%

Return on Assets

3.35%

Free Cashflow Yield

11.97%

CVS Fundamentals

CVS Revenue

Revenue (TTM)

357.8B

Rev. Growth (Yr)

11.89%

Rev. Growth (Qtr)

4.51%

CVS Earnings

Earnings (TTM)

8.4B

Earnings Growth (Yr)

-12.54%

Earnings Growth (Qtr)

-9.93%

Breaking Down CVS Revenue

Last 7 days

-7.4%

Last 30 days

-10.9%

Last 90 days

-10.9%

Trailing 12 Months

-7.7%

How does CVS drawdown profile look like?

CVS Financial Health

Current Ratio

0.86

Debt/Equity

0.77

Debt/Cashflow

0.23

CVS Investor Care

Dividend Yield

3.51%

Dividend/Share (TTM)

2.42

Buy Backs (1Y)

2.00%

Diluted EPS (TTM)

6.47

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023330.9B339.2B347.8B357.8B
2022299.8B307.9B315.2B322.5B
2021271.0B278.3B285.1B292.1B
2020261.9B263.8B266.0B268.7B
2019210.5B227.0B244.3B256.8B
2018186.0B187.2B188.5B194.6B
2017178.8B180.8B182.4B184.8B
2016160.2B166.7B172.7B177.5B
2015143.0B145.6B149.2B153.3B
2014128.7B132.1B135.1B139.4B
2013123.1B123.6B125.3B126.8B
2012112.2B116.5B120.0B123.1B
201197.9B100.4B103.4B107.1B
201098.9B97.9B97.0B95.8B
200989.5B93.3B97.0B98.7B
2008080.0B83.8B87.5B
200700076.3B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of CVS Health Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
lynch karen s
acquired
3,599,930
79.56
45,248
president and ceo
Apr 01, 2024
cowhey thomas f.
acquired
-
-
15,082
evp and cfo
Apr 01, 2024
lynch karen s
sold (taxes)
-4,928,980
79.56
-61,953
president and ceo
Apr 01, 2024
joyner j. david
acquired
-
-
28,280
evp&president-pharmacyservices
Apr 01, 2024
khichi samrat s.
acquired
-
-
12,569
evp, cpo and general counsel
Apr 01, 2024
cowhey thomas f.
sold (taxes)
-136,764
79.56
-1,719
evp and cfo
Apr 01, 2024
havanec laurie p.
sold (taxes)
-607,043
79.56
-7,630
evp and chief people officer
Apr 01, 2024
kane brian a
acquired
-
-
12,569
evp/president, aetna
Apr 01, 2024
chaguturu sreekanth k
sold (taxes)
-182,829
79.56
-2,298
evp and chief medical officer
Apr 01, 2024
clark james david
acquired
849,940
79.56
10,683
svp, cont & chief acct officer

1–10 of 50

Which funds bought or sold CVS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 15, 2024
Future Financial Wealth Managment LLC
added
100
400,491
792,652
0.30%
Apr 15, 2024
F&V Capital Management, LLC
added
1.21
232,000
10,651,000
3.14%
Apr 15, 2024
Atlas Private Wealth Management, LLC
reduced
-14.19
-44,103
286,976
0.12%
Apr 15, 2024
RMR Wealth Builders
added
15.89
181,840
1,247,560
0.15%
Apr 15, 2024
BEACH INVESTMENT COUNSEL INC/PA
unchanged
-
-
2,342,000
0.29%
Apr 15, 2024
MATRIX ASSET ADVISORS INC/NY
reduced
-2.55
-358,099
22,631,400
2.71%
Apr 15, 2024
GoalVest Advisory LLC
sold off
-100
-3,790
-
-%
Apr 15, 2024
BURKE & HERBERT BANK & TRUST CO
unchanged
-
3,748
373,755
0.28%
Apr 15, 2024
St. Johns Investment Management Company, LLC
added
37.75
399,406
1,419,650
0.68%
Apr 15, 2024
VIKING FUND MANAGEMENT LLC
unchanged
-
28,000
2,791,600
0.50%

1–10 of 50

Are Funds Buying or Selling CVS?

Are funds buying CVS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CVS
No. of Funds

Unveiling CVS Health Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.14%
117,681,195
SC 13G/A
Jan 26, 2024
blackrock inc.
6.8%
87,020,610
SC 13G/A
Feb 09, 2023
vanguard group inc
8.94%
117,533,372
SC 13G/A
Feb 07, 2023
blackrock inc.
7.4%
96,668,258
SC 13G/A
Feb 09, 2022
vanguard group inc
8.28%
109,236,922
SC 13G/A
Feb 01, 2022
blackrock inc.
7.1%
93,556,500
SC 13G/A
Feb 10, 2021
vanguard group inc
8.05%
105,383,923
SC 13G/A
Jan 29, 2021
blackrock inc.
7.1%
92,478,369
SC 13G/A
Feb 12, 2020
vanguard group inc
8.05%
104,808,202
SC 13G/A
Feb 05, 2020
blackrock inc.
7.2%
94,158,010
SC 13G/A

Recent SEC filings of CVS Health Corp

View All Filings
Date Filed Form Type Document
Apr 05, 2024
ARS
ARS
Apr 05, 2024
DEF 14A
DEF 14A
Apr 05, 2024
DEFA14A
DEFA14A
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading

Peers (Alternatives to CVS Health Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
432.4B
371.6B
-9.23% -12.95%
19.32
1.16
14.64% 11.24%
101.4B
195.3B
-0.90% 34.65%
18.87
0.52
8.17% -20.79%
86.8B
357.8B
-10.90% -7.68%
10.4
0.24
10.95% 93.52%
83.0B
65.0B
0.18% 18.00%
15.84
1.28
7.86% -7.11%
38.7B
154.0B
-3.67% 6.80%
14.31
0.25
6.54% 124.79%
11.4B
12.1B
-4.93% 54.73%
16.46
0.94
4.57% 23.40%
11.2B
14.3B
-4.30% 22.39%
15.59
0.78
6.59% 6.24%
MID-CAP
9.3B
2.3B
-4.81% 9.59%
34.17
4.11
6.06% 9.17%
6.7B
2.9B
-6.00% -3.46%
-311.45
2.3
12.20% -107.93%
2.2B
3.8B
-2.74% -34.13%
10.21
0.57
-27.73% -52.50%
2.1B
1.4B
-1.50% 0.56%
34.59
1.51
21.19% 34.42%
SMALL-CAP
1.6B
1.1B
0.06% -12.91%
25.15
1.48
11.31% 35.83%
1.2B
3.0B
5.33% 55.67%
-6.31
0.4
6.74% 20.73%
48.4M
-
-23.65% -14.81%
-3.31
-
- -12.94%
18.2M
21.3M
11.67% 2.14%
34.08
0.85
8.00% -62.25%

CVS Health Corp News

Latest updates
MarketWatch4 hours ago
Yahoo Finance03 Apr 202407:00 am

CVS Health Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue4.5%93,81389,76488,92185,27883,84681,15980,63676,82676,60473,79472,61669,09769,55467,05665,34166,75566,88964,81063,43161,64654,424
Costs and Expenses5.1%90,44086,07485,68781,83280,18785,07875,96773,28174,25870,73368,29065,52067,03063,80760,66163,29763,85261,88260,09958,95653,600
Operating Expenses-------9,1719,876--8,8698,922-8,4718,6688,5638,6548,5958,0428,2506,613
EBITDA Margin-3.9%0.05*0.05*0.03*0.04*0.04*0.03*0.06*0.06*0.06*0.06*0.06*0.06*---------
Interest Expenses-0.4%690693686589552566583586608602636657678731765733734747772782733
Income Taxes-12.7%658754656737818-1,0451,090646300558944746241587974767590604660512524
Earnings Before Taxes-10.4%2,7053,0192,5702,8793,150-4,4444,1293,0011,6872,1453,7352,9701,2251,8063,9602,7792,3342,1332,5911,939102
EBT Margin-6.5%0.03*0.03*0.01*0.02*0.02*0.01*0.04*0.04*0.04*0.04*0.03*0.04*---------
Net Income-9.9%2,0372,2611,9142,1422,329-3,4063,0392,3551,3931,5982,7912,2249651,2242,9862,0121,7471,5301,9361,421-419
Net Income Margin-6.1%0.02*0.02*0.01*0.01*0.01*0.01*0.03*0.03*0.03*0.03*0.03*0.03*---------
Free Cashflow-263.4%-3,5472,1715,3176,454-2,6408,5435,0352,5123,4084,9135,3612,063---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-0.6%249,728251,306250,071239,330228,275231,212230,279232,873233,052234,891231,164229,606230,715232,898235,495230,639222,449220,113218,904219,768196,456
  Current Assets-3.3%67,85870,14367,75668,70665,63368,34162,14261,48360,03560,84256,55955,71956,36959,21162,50658,95850,30248,18546,90147,85745,243
    Cash Equivalents-37.2%8,19613,04313,80714,61812,94517,56312,46311,6119,4089,8267,1195,59811,0439,53215,14510,3378,4085,4696,3386,1686,553
  Inventory0.4%18,02517,95417,29118,26319,09018,05817,37518,16017,76017,39916,97917,61818,49617,47816,51916,97617,51616,02815,51115,44816,450
  Net PPE-100.0%-13,02213,00112,87212,87312,62612,76412,84412,89612,77112,66412,61112,60612,34912,22112,14612,04411,65111,48311,34811,349
  Goodwill0.0%91,27291,26191,2605,90978,15078,08678,56079,06079,12179,12179,55279,55279,55279,57980,05779,99379,74979,54879,48579,07578,678
Liabilities-2.1%173,092176,796177,069167,750156,506160,201154,773158,733158,211160,273157,599158,442161,014163,786167,140165,165158,279157,180157,305159,762137,913
  Current Liabilities-2.9%79,18981,55379,20675,05469,42172,40968,45769,78067,71964,70959,31160,10462,01762,04463,69459,56053,30352,54449,37650,63144,009
  Short Term Borrowings-200-1,000--------252---255-1,0704463,005720
  Long Term Debt-1.9%58,63859,78261,41956,45050,47650,84850,79752,06351,97156,83259,29459,27059,20761,55263,48165,73564,69964,20666,94167,88871,444
    LT Debt, Current---------------8,1925,8283,7813,7783,8943,8931,265
    LT Debt, Non Current---------------63,48165,73564,69964,20666,94167,88871,444
Shareholder's Equity2.9%76,46174,33773,00271,58071,46971,48775,73674,03474,84174,61873,56571,16469,70169,11268,35565,47464,17062,93361,59960,00658,543
  Retained Earnings2.1%61,60460,34358,86857,75356,39854,57158,71056,48854,99754,26453,33151,20349,64049,32848,76846,45545,10844,01743,13641,85940,911
Shares Outstanding0.1%1,2881,2871,2821,2791,3001,3131,3131,3121,3191,3181,3161,313---------
Minority Interest1.2%175173276198300328322310306310321314312305333334306319317320318
Float---88,548---121,258---109,651---84,719---70,618--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-197.1%-2,6362,7165,9087,438-1,9529,1235,4433,5634,0055,5215,8472,8923,5671,8747,1193,3052,6342,9285,3381,9482,479
  Share Based Compensation-17.5%12715420410310610514789.0013811414587.0011210983.0096.0098.00129112114108
Cashflow From Investing-61.1%-1,242-771-10,362-8,514-119-805-2,130-1,993-1,440-847-1,107-1,867-1,234-1,370-1,333-1,597-709-829-910-891-41,899
Cashflow From Financing64.0%-972-2,6973,6262,726-2,187-3,218-2,461-2,650-2,914-1,930-3,327-3,185-3,276-6,117-9782,675-1,244-2,968-4,2588161,892
  Dividend Payments0%779779795779719726740722660659650656644665663652651646657649510
  Buy Backs66.7%-1.00-3.00-2.002,0181,500--2,000-------------

CVS Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:   
Premiums$ 99,192$ 85,330$ 76,132
Net investment income1,1538381,199
Total revenues357,776322,467292,111
Operating costs:   
Cost of products sold217,098196,892175,803
Health care costs86,24771,07364,188
Restructuring charges50700
Opioid litigation charges05,8030
Loss on assets held for sale3492,5330
Store impairments001,358
Goodwill impairment00431
Operating expenses39,83238,21237,021
Total operating costs344,033314,513278,801
Operating income13,7437,95413,310
Interest expense2,6582,2872,503
Loss on early extinguishment of debt00452
Other income(88)(169)(182)
Income before income tax provision11,1735,83610,537
Income tax provision2,8051,5092,548
Net income8,3684,3277,989
Net (income) loss attributable to noncontrolling interests(24)(16)12
Net income attributable to CVS Health$ 8,344$ 4,311$ 8,001
Net income per share attributable to CVS Health:   
Basic (in dollars per share)$ 6.49$ 3.29$ 6.07
Diluted (in dollars per share)$ 6.47$ 3.26$ 6.02
Weighted average shares outstanding:   
Basic (in shares)1,2851,3121,319
Diluted (in shares)1,2901,3231,329
Dividends declared per share (in dollars per share)$ 2.42$ 2.20$ 2.00
Cost, Product and Service [Extensible List]ProductsProductsProducts
Products   
Revenues:   
Revenues$ 245,138$ 226,616$ 203,738
Services   
Revenues:   
Revenues$ 12,293$ 9,683$ 11,042

CVS Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets:  
Cash and cash equivalents$ 8,196$ 12,945
Investments3,2592,778
Accounts receivable, net35,22727,276
Inventories18,02519,090
Assets held for sale0908
Other current assets3,1512,636
Total current assets67,85865,633
Long-term investments23,01921,096
Property and equipment, net13,18312,873
Operating lease right-of-use assets17,25217,872
Goodwill91,27278,150
Intangible assets, net29,23424,803
Separate accounts assets3,2503,228
Other assets4,6604,620
Total assets249,728228,275
Liabilities:  
Accounts payable14,89714,838
Pharmacy claims and discounts payable22,87419,423
Health care costs payable12,049 
Health care costs payable 10,142
Policyholders’ funds1,3261,500
Accrued expenses22,18918,745
Other insurance liabilities1,1411,089
Current portion of operating lease liabilities1,7411,678
Short-term debt2000
Current portion of long-term debt2,7721,778
Liabilities held for sale0228
Total current liabilities79,18969,421
Long-term operating lease liabilities16,03416,800
Long-term debt58,63850,476
Deferred income taxes4,3114,016
Separate accounts liabilities3,2503,228
Other long-term insurance liabilities5,4595,835
Other long-term liabilities6,2116,730
Total liabilities173,092156,506
Commitments and contingencies (Note 18)
Shareholders’ equity:  
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding00
Common stock, par value $0.01: 3,200 shares authorized; 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus48,99248,193
Treasury stock, at cost: 480 and 458 shares at December 31, 2023 and 2022(33,838)(31,858)
Retained earnings61,60456,398
Accumulated other comprehensive loss(297)(1,264)
Total CVS Health shareholders’ equity76,46171,469
Noncontrolling interests175300
Total shareholders’ equity76,63671,769
Total liabilities and shareholders’ equity$ 249,728$ 228,275
CVS
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
 CEO
 WEBSITEcvshealth.com
 INDUSTRYHealthcare Plans
 EMPLOYEES65535

CVS Health Corp Frequently Asked Questions


What is the ticker symbol for CVS Health Corp? What does CVS stand for in stocks?

CVS is the stock ticker symbol of CVS Health Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CVS Health Corp (CVS)?

As of Mon Apr 15 2024, market cap of CVS Health Corp is 86.78 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CVS stock?

You can check CVS's fair value in chart for subscribers.

What is the fair value of CVS stock?

You can check CVS's fair value in chart for subscribers. The fair value of CVS Health Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of CVS Health Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CVS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is CVS Health Corp a good stock to buy?

The fair value guage provides a quick view whether CVS is over valued or under valued. Whether CVS Health Corp is cheap or expensive depends on the assumptions which impact CVS Health Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CVS.

What is CVS Health Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, CVS's PE ratio (Price to Earnings) is 10.39 and Price to Sales (PS) ratio is 0.24. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CVS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CVS Health Corp's stock?

In the past 10 years, CVS Health Corp has provided 0.014 (multiply by 100 for percentage) rate of return.